Abstract
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potential target for treatment of diabetes and metabolic syndrome. Docking and pharmacophore modeling have been used to discover novel inhibitors of 11β-HSD1. Several compounds, with large structural diversity and good potency against 11β-HSD1, have been found and their potency was determined by the enzyme assay. New scaffolds of 11β-HSD1 inhibitors are also reported.
| Original language | English |
|---|---|
| Pages (from-to) | 1340-1345 |
| Number of pages | 6 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| State | Published - 15 Feb 2008 |
| Externally published | Yes |
Keywords
- 11β-HSD1
- 11β-HSD2
- Docking
- Inhibitor
- Pharmacophore